Literature DB >> 15143188

Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling.

Edward P Feener1, Felicia Rosario, Sarah L Dunn, Zlatina Stancheva, Martin G Myers.   

Abstract

Jak family tyrosine kinases mediate signaling by cytokine receptors to regulate diverse biological processes. Although Jak2 and other Jak kinase family members are phosphorylated on numerous sites during cytokine signaling, the identity and function of most of these sites remains unknown. Using tandem mass spectroscopic analysis of activated Jak2 protein from intact cells, we identified Tyr(221) and Tyr(570) as novel sites of Jak2 phosphorylation. Phosphorylation of both sites was stimulated by cytokine treatment of cultured cells, and this stimulation required Jak2 kinase activity. While we observed no gross alteration of signaling upon mutation of Tyr(221), Tyr(570) lies within the inhibitory JH2 domain of Jak2, and mutation of this site (Jak2(Y570F)) results in constitutive Jak2-dependent signaling in the absence of cytokine stimulation and enhances and prolongs Jak2 activation during cytokine stimulation. Mutation of Tyr(570) does not alter the ability of SOCS3 to bind or inhibit Jak2, however. Thus, the phosphorylation of Tyr(570) in vivo inhibits Jak2-dependent signaling independently of SOCS3-mediated inhibition. This Tyr(570)-dependent mechanism of Jak2 inhibition likely represents an important mechanism by which cytokine function is regulated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143188      PMCID: PMC416405          DOI: 10.1128/MCB.24.11.4968-4978.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.

Authors:  T C Yeh; E Dondi; G Uze; S Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 2.  Signaling by the cytokine receptor superfamily.

Authors:  J N Ihle; W Thierfelder; S Teglund; D Stravopodis; D Stravapodis; D Wang; J Feng; E Parganas
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

Review 3.  Obesity and the hypothalamus: novel peptides for new pathways.

Authors:  J S Flier; E Maratos-Flier
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

4.  Jak2 is essential for signaling through a variety of cytokine receptors.

Authors:  E Parganas; D Wang; D Stravopodis; D J Topham; J C Marine; S Teglund; E F Vanin; S Bodner; O R Colamonici; J M van Deursen; G Grosveld; J N Ihle
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

5.  Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity.

Authors:  Y J Zhou; E P Hanson; Y Q Chen; K Magnuson; M Chen; P G Swann; R L Wange; P S Changelian; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop.

Authors:  J Feng; B A Witthuhn; T Matsuda; F Kohlhuber; I M Kerr; J N Ihle
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

Review 7.  The leptin receptor.

Authors:  L A Tartaglia
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

8.  SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985.

Authors:  C Bjorbak; H J Lavery; S H Bates; R K Olson; S M Davis; J S Flier; M G Myers
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

9.  Activation of downstream signals by the long form of the leptin receptor.

Authors:  A S Banks; S M Davis; S H Bates; M G Myers
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

10.  The role of SOCS-3 in leptin signaling and leptin resistance.

Authors:  C Bjørbaek; K El-Haschimi; J D Frantz; J S Flier
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

View more
  39 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

Review 2.  Molecular and neural mediators of leptin action.

Authors:  Scott A Robertson; Gina M Leinninger; Martin G Myers
Journal:  Physiol Behav       Date:  2008-04-13

3.  Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation.

Authors:  Jacqueline Sayyah; Kavitha Gnanasambandan; Sushama Kamarajugadda; Shigeharu Tsuda; Jennifer Caldwell-Busby; Peter P Sayeski
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

4.  Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish.

Authors:  Sara M N Onnebo; Parisa Rasighaemi; Janani Kumar; Clifford Liongue; Alister C Ward
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

Review 5.  Molecular insights into regulation of JAK2 in myeloproliferative neoplasms.

Authors:  Olli Silvennoinen; Stevan R Hubbard
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

6.  Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.

Authors:  Wanlong Ma; Hagop Kantarjian; Xi Zhang; Chen-Hsiung Yeh; Zhong J Zhang; Srdan Verstovsek; Maher Albitar
Journal:  J Mol Diagn       Date:  2008-12-12       Impact factor: 5.568

7.  JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs.

Authors:  Friederike Pastore; Aishwarya Krishnan; Henrik M Hammarén; Olli Silvennoinen; Benedict Yan; Ross L Levine
Journal:  Blood Adv       Date:  2020-09-22

8.  Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity.

Authors:  Megumi Funakoshi-Tago; Stéphane Pelletier; Hiroshi Moritake; Evan Parganas; James N Ihle
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

9.  Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells.

Authors:  Xiuting Chen; Zhe Ying; Xi Lin; Huanxin Lin; Jueheng Wu; Mengfeng Li; Libing Song
Journal:  J Clin Invest       Date:  2013-05-08       Impact factor: 14.808

Review 10.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.